Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Cutaneous Manifestations of Mastocytosis

Description

Doctor Karen Hartman, a professor of medicine and head of the Division of Allergy at the University Hospital in Basel, Switzerland, presented on the cutaneous manifestations of mastocytosis. Mastocytosis involves an expansion of mast cells in tissues, especially skin, often seen in three categories: cutaneous mastocytosis, systemic mastocytosis (which may be indolent or advanced), and very rarely, mast cell sarcoma. The most common form is indolent systemic mastocytosis, usually associated with skin involvement and distinct lesions. Key features include the Darier sign, where lesions swell upon scratching. Cutaneous mastocytosis presents in children as mastocytoma or urticaria pigmentosa, while adults typically have a monomorphic variant. The prognosis for childhood forms is generally good, often resolving by adolescence, whereas adult cases tend to persist. Diagnostic approaches include assessing skin lesions, measuring serum tryptase levels, and identifying the KIT DH16V mutation. Advanced systemic mastocytosis may warrant further tests like bone marrow biopsies. Treatment options include managing symptoms, epinephrine auto-injectors for anaphylaxis, and emerging tyrosine kinase inhibitors like evaicritinib, showing some promise for improving skin lesions. Hartman emphasized the importance of collaborative care among dermatologists and researchers to enhance patient outcomes.

View more

Conclusions

  • Specific skin lesions, recurrent anaphylaxis, increased tryptase levels, and osteoporosis are common presenting signs of mastocytosis.
  • Mastocytosis is a heterogeneous disease that involves an accumulation of mast cells in the skin, bone marrow, and other organs.
  • The presence of the KIT D816V mutation is prevalent in most mastocytosis patients and contributes to disease progression.
  • Darier's sign is a useful clinical examination tool for confirming suspicion of cutaneous mastocytosis.
  • Skin lesion frequency varies by mastocytosis category, with cutaneous mastocytosis showing nearly universal lesions while advanced systemic mastocytosis has lower involvement.
  • New treatments such as tyrosine kinase inhibitors may offer effective management for patients with cutaneous and systemic mastocytosis.
  • The work-up for mastocytosis includes skin inspection, serum tryptase level measurement, and assessment for the presence of the KIT D816V mutation.
  • Hoermann ... Hartmann ... Arock, J Allergy Clin Immunol Pract 2022
  • Jawhar et al, J Clin Oncol 2019
  • Hartmann et al, J Allergy Clin Immunol 2016
  • Hartmann, Horny, Valent, WHO Classification of Skin Tumours 2018
  • Valent, Hartmann et al, J Allergy Clin Immunol Pract 2024
  • Wassmer, Hartmann, Monatsschr Kinderheilk 2023
  • Gebhard et al, J Eur Acad Dermatol 2022
  • Sprinzl et al, Int J Mol Sci 2021
  • Greiner et al, Blood 2021
  • Maurer ... Hartmann, AAAAI Abstract 2023